March 24, 2022

/

Ecuador and China sign cooperation agreement for vaccine production

Fundación Andrés Bello

Photo: Dr. Ximena Garzón Villalba, Ecuador´s Ministry of Public Health By: Asamblea Nacional del Ecuador. Source: Flickr

In February 2022, the Ecuadorian Minister of Health, Ximena Garzón, visited the People's Republic of China to attend various meetings geared towards strengthening cooperation in the area of public health. Following the visit, the Minister authorized the installation in Ecuador of a factory to manufacture Chinese-made vaccines against COVID-19 and other regular vaccines.

The agreement was signed with the pharmaceutical company Sinovac Life Science Co. Ltd, and will lead to Ecuador and China working together on three main lines of action to produce biologics. The first is the implementation of clinical trials in the country; the second is technical, scientific, and technological strengthening and transfer; and the third consists of a training and knowledge transfer system. The meeting was attended by Gao Qiang, General Manager of Sinovac; Jack Tang, Sinovac Operations Manager for Latin America and the Caribbean; Ximena Garzón, Minister of Public Health; Lorena Konanz Baquerizo, Minister of Production, Foreign Trade, Investment, and Fisheries; and Roberto Salas Guzmán, Technical Secretary of Public-Private Partnerships. During the signing of the agreement, the Minister mentioned that this scientific advance is a great achievement for Ecuador.

Main story:

El Comercio: Ecuador firma compromiso de cooperación con China para la producción de vacunas.

La embajada de las becas

September 30, 2026

The Embassy of Scholarships

Editorials, Guatemala 🇬🇹

La embajada de las cosas

September 22, 2026

The Embassy of Things

Editorials, Guatemala 🇬🇹, News & Analysis

China y Taiwán en el imaginario guatemalteco

September 21, 2026

China and Taiwan in the Guatemalan Imaginary

Editorials, Guatemala 🇬🇹

Learn more about the Andrés Bello Foundation

MEET THE TEAM

Team →

LEAVE US A MESSAGE

Contact →

FOLLOW US ON

STAY UP TO DATE
SUBSCRIBE TO OUR NEWSLETTER